Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

NDTV Profit tracks what analysts are saying about various stocks and sectors. Here are the analyst calls to keep an eye out ...

Q3 standalone net profit increased to Rs 11,790 crore from Rs 10,270 crore (Y-o-Y), beating estimates of Rs 11,330 crore ...

The Dhaka Stock Exchange (DSE) continued its downward trend today, with the benchmark DSEX index dropping by 70 points over three consecutive sessions.  This extended period of negative market ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The healthcare sector has struggled to deliver worthwhile returns for investors since 2021, weighed down by several headwinds ...

Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, ...

The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

JPMorgan Chase & Co. lessened its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 93.9% in the third quarter ...

Stock gains always get people talking, and 2025 is no exception. Markets have moved higher for a while due to a shift toward tech innovation.

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...